Skip to content

Clinical Study of Comorbidities of Attention Deficit Hyperactivity in Children and Adolescents.

Clinical Study of Comorbidities of Attention Deficit Hyperactivity in Children and Adolescents.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04946877
Enrollment
200
Registered
2021-07-01
Start date
2022-03-01
Completion date
2022-10-01
Last updated
2022-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Hyperactivity Disorder

Keywords

ADHD,comorbidities

Brief summary

Determine the frequency of psychiatric and neurological comorbidities in children and adolescence diagnosed with ADHD.

Detailed description

ADHD is a common neurodevelopmental disorder characterized by hyperactivity, impulsivity, and inattention .ADHD is more often a complex disorder with a high rate of associated co-morbid conditions. Co-morbid conditions are prevalent among people with ADHD and increase its burden and complexity of management.Children with ADHD are at a higher risk than children without ADHD for developing other psychiatric disorders .Motor skill problems and Neurological soft signs are found in many neuropsychiatric conditions .NSS have been associated with inattention and behaviour difficulties for decades. Some researchers argue that these signs should be included in the diagnosis of ADHD .

Interventions

DIAGNOSTIC_TESTIQ assessment using Wechsler intelligence scale for children third edition (WISC-III)

IQ assessment using Wechsler intelligence scale for children third edition (WISC-III): is consists of several subtests, each classified into a verbal or performance scale .

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 17 Years

Inclusion criteria

* Age: 6-17 years. * Sex: both sexes will be included in the study. * IQ≥70.

Exclusion criteria

* Age: less than 6 years or more than 17 years. * IQ\<70. * Patients with major neurological deficits, cerebral palsy and uncontrolled epilepsy. * Patients with major psychiatric disorders e.g schizophrenia spectrum disorder. * Patient who refusing to participate in the study or their caregiver refusing to give informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Determine psychiatric comorbidities in children and adolescents with ADHD using Mini international neuropsychiatric interview for children and adolescents (M.I.N.I. Kid).baselineMini international neuropsychiatric interview for children and adolescents (M.I.N.I. Kid): is structured clinical diagnostic interview designed to assess the presence of current ICD-10 and DSM-IV psychiatric disorders in children and adolescents age 6-17 years

Secondary

MeasureTime frameDescription
determinate presence of soft neurological sign in children and adolescents with ADHD using Cambridge neurological inventory.baselineNeurological assessment using Cambridge neurological inventory: this is a clinical instrument constructed for standardized neurological assessment of psychiatric patients. It is useful for identifying neurological soft sign and other patterns of neurological impairments

Contacts

Primary Contactsalma mohmed fahmi, msc
saloma151@yahoo.com01067151755
Backup ContactAhmed Abdelbaky Abd elrahman, MD

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026